melanoma

Oncology
blood cancer history

A history of blood cancer treatment

Despite being one of the most common forms of cancer, awareness of blood cancer pales in comparison to other types of the disease.

News
BMS_Nassau_Park

Opdualag off to a flying start, says BMS CEO

Bristol-Myers Squibb's new immune checkpoint inhibitor combination Opdualag has only been on the US market for a few weeks but is already off to a "great start", according to chief executiv